Title A Multimodal Interventional Approach in ClinicalSexology:
Integration of Oral Pharmacotherapy, Low-Intensity Shockwave Therapy, PRP, and Vipassana Meditation in the Management of Low Libido, ErectileDysfunction, and Premature Ejaculation.AuthorDr. Ramesh Maheshwari, MBBS, MD, PhD (Sexual Medicine)Founder & Director, WNHO Group of Institutions, WNHO Institute of Sexology& Psychosexual Counselling Pune, India.Email -drrameshm2@gmail.comWebsite -www.sexologyinstitute.co.in/ www.wnhohealthcare.com.
1. Introduction
Sexual dysfunction among men is a rising concern in modern clinical practice, often linked to both organic and psychogenic causes. Traditional oral therapies including PDE5 inhibitors and SSRIs have limitations, especially in treatment-resistant cases.
Recent developments in regenerative medicine—namely LiSWT and PRP—alongside non-pharmacologic interventions such as Vipassana meditation, offer potential for a paradigm shift in management strategy.
2. Materials and Methods.
1 Study Design & PopulationA prospective, comparative study conducted at WNHO Clinics in Pune and Surat (2023–2024). Inclusion criteria were: Males aged 25–60 years Diagnosed with ED (IIEF-5 < 20), PE (IELT < 1.5 min), and/or low libido (SDI-M < 30) No major endocrine disorders or anatomical abnormalities2.
2 Interventions Oral Therapy: Tadalafil 2.5 mg mg OD, Dapoxetine 30 mg , Maca root, and L-Arginine supplementation. LiSWT: 6 sessions, twice weekly (Radial waves, 2000 shocks/session, 0.09 mJ/mm²). PRP:
2 Autologous PRP injected intracavernosally at baseline and 4 weeks. Vipassana Meditation: Standard 10-day residential course (SN Goenka Tradition).2.3 Assessment Tools Erectile Function: IIEF-5 Ejaculation: IELT (measured via stopwatch method) Sexual Desire: Sexual Desire Inventory – Male (SDI-M) Psychological Parameters: Beck Depression Inventory-II (BDI-II), Perceived Stress Scale (PSS-10)2.4 Statistical AnalysisData analysed using SPSS 27. ANOVA and paired Significance threshold set at p < 0.05. AbstractBackground: Erectile dysfunction (ED), premature ejaculation (PE), and hypoactive sexual desire disorder (HSDD/Low Libido) are prevalent conditions with multifactorial aetiology in Male. While oral therapies remain a cornerstone of treatment, emerging regenerative and psychobehavioral interventions offer promising adjunctive benefits.Objective: To evaluate the synergistic efficacy of combined oral pharmacotherapy, Low-Intensity Shockwave Therapy (LiSWT), autologous Platelet-Rich Plasma (PRP), and Vipassana meditation in male patients presenting with low libido, ED, and PE.Methods: A prospective interventional cohort study involving 60 male patients aged 25–60 years presenting with sexualdys functions. Participants were divided into three arms: Group
A: Oral therapy alone Group
B: Oral therapy + LiSWT + PRP Group
C: Oral therapy + LiSWT + PRP + Vipassana meditation (10-day residential program)Assessments were done at baseline, 4 weeks, and 12 weeks using IIEF-5, IELT, and SDI-M for sexual desire. Psychological status was evaluated using the Beck Depression Inventory (BDI-II) and Perceived Stress Scale (PSS-10).Results: Group C showed the highest improvement across all domains. IIEF-5 improved by 42% in Group C, 31% in Group B, and 19% in Group A. IELT improved by 2.6 min in Group C vs 1.9 min (B) and 0.8 min
(A).Sexual desire index improved significantly (p<0.01) in Group Cpost-Vipassana. Stress and depression scores were notably reduced in Group C.3. Results Parameter Group A (Oral only)
Group B (Oral+LiSWT+PRP) Group C (Oral+LiSWT+PRP+Vipassana) IIEF-5 Improvement +3.2 points +5.8 points +7.2 points IELT (Baseline vs 12 weeks) 0.9 → 1.7 min 1.1 → 3.0 min 1.0 → 3.6 min SDI-M Score ↑ +4.8 +8.3 +12.7 PSS-10 ↓ -2.1 -4.5 -6.8 BDI-II ↓ -3.3 -5.0 -7.4 Statistically significant intergroup differences were observed in all primary outcomes (p < 0.01). Group C participants reported enhanced body awareness, libido restoration, and decreased performance anxiety.
Conclusion:
A holistic, integrative model combining biological, regenerative, and mindfulness-based therapies demonstrates superior outcomes in treating male sexual dysfunction. Vipassana meditation appears to enhance neuroendocrine regulation, contributing to libido restoration and psychosexual balance. The study supports a bio-psycho-social model in clinical sexology. While oral pharmacotherapy is essential, LiSWT and PRP facilitate tissue repair, endothelial neovascularization, and nerve regeneration.
Vipassana, through its influence on mindfulness, stress reduction, and emotional regulation, optimizes psychosexual functioning and neuroendocrine balance.Neuroimaging evidence supports enhanced activity in the prefrontal cortex and hypothalamus following mindfulness practices. This may explain the improved libido and control over ejaculatory reflexes. The integration of regenerative therapies with psychobehavioral practices yields substantial benefits in male sexual dysfunction.. Vipassana meditation may represent a vital, cost-effective modality for longterm psychological and sexual well-being. KeywordsErectile Dysfunction, Premature Ejaculation, Low Libido, Shockwave Therapy, PRP, Vipassana, Clinical Sexology, Regenerative SexualMedicine AcknowledgementsWe acknowledge the support of WNHO Clinical Research Unit and the staff at the affiliated meditation centres. Gratitude is extended to the participants for their openness and commitment.Self-funded by Dr. Ramesh Maheshwari under WNHO Health CarePune's internal research grant initiative.